Please login to the form below

Not currently logged in
Email:
Password:

EACCME to announce new accreditation guidelines at forthcoming CME Forum

The announcement will coincide with the gCMEp’s celebration of their own peer review publication of their own guidelines 

The complete programme for the 2012 European CME Forum is still being finalised, however, organisers are expecting the European Accreditation Council for Continuing Medical Education Institute (EACCME), which is part of the European Union of Medical Specialists (UEMS), to use the event to announce important new accreditation guidelines.

Also present will be the Good CME Practice Group (gCMEp), who will hopefully be celebrating the peer review publication of their long awaited guidelines and debating where to go next.

Other confirmations include, Edwin Borman, the new secretary general of UEMS/EACCME, Murray Kopelow, architect of the ACCME in the US, Pam Montgomery, deputy CEO for the Royal Australasian College of Surgeons, as well as European pharma representatives all in the same room at the same time, which has the potential to be very insightful.

The fifth annual meeting of the European CME Forum will be taking place from 15 to 16 November this year, at the Millennium Gloucester Hotel & Conference Centre in London.

For more information on the event, please visit www.europeancmeforum.eu or contact project director Peter Llewellyn directly on +44 (0) 1865 784390 / support@europeancmeforum.eu

10th September 2012

From: Marketing, Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics